Published by Josh White on 1st August 2019
(Sharecast News) - Clinical-stage biotechnology company ValiRx announced on Thursday that the European Patent Office has issued a Patent Notice of Allowance for its preclinical therapeutic compound 'VAL301', subject to payment of the relevant fees.
URL: http://www.digitallook.com/dl/news/story/29383146/...